<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JDM</journal-id><journal-title-group><journal-title>Journal of Diabetes Mellitus</journal-title></journal-title-group><issn pub-type="epub">2160-5831</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jdm.2015.54039</article-id><article-id pub-id-type="publisher-id">JDM-61391</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Personality Traits, Medication Beliefs &amp; Adherence to Medication among Diabetic Patients Attending the Diabetic Clinic in a Teaching Hospital in Southwest Nigeria
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>deyinka</surname><given-names>Adeniran</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Modupe</surname><given-names>Akinyinka</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kikelomo</surname><given-names>O. Wright</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Omowumi</surname><given-names>Q. Bakare</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Olayinka</surname><given-names>O. Goodman</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yetunde</surname><given-names>A. Kuyinu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Olumuyiwa</surname><given-names>O. Odusanya</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Akin</surname><given-names>Osibogun</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Department of Community Health and Primary Care, College of Medicine, University of Lagos, Lagos, Nigeria</addr-line></aff><aff id="aff1"><addr-line>Department of Community Health and Primary Health Care, College of Medicine, Lagos State University, Lagos, Nigeria</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>yinkadeniran@yahoo.com(DA)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>09</month><year>2015</year></pub-date><volume>05</volume><issue>04</issue><fpage>319</fpage><lpage>329</lpage><history><date date-type="received"><day>28</day>	<month>October</month>	<year>2015</year></date><date date-type="rev-recd"><day>accepted</day>	<month>21</month>	<year>November</year>	</date><date date-type="accepted"><day>24</day>	<month>November</month>	<year>2015</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: Non-adherence to drug therapy is an important cause of treatment failure among pa
  tients with chronic conditions like diabetes. Previous researches have presented associations
   among personality traits, medication beliefs and adherence to long-term medication treatment in individuals with different chronic diseases. However, there is limited knowledge about associations among personality traits, medication belief and adherence to diabetic treatment in Africa. It was on this basis that this study was undertaken to assess the personality traits and personal beliefs of patients on medication for Diabetes Mellitus (DM) and to also assess adherence to treatment. Methodology: This study was a descriptive cross sectional study. Using a systematic random sampling technique, 223 patients attending the diabetic clinic of Lagos State University Teaching Hospital, Lagos were selected over a period of 12 weeks. Patients were interviewed using the Big Five-factor Personality Inventory, Medication Belief Questionnaire and the Medication Adherence 
  Report Scale. Data were statistically analyzed using descriptive statistics, Student’s t-tests, Chi 
  Square Tests and Pearson’s correlations analysis. Results: Non-adherence was estimated to be 
  40.8%. Non-adherent respondents had lower mean score of neuroticism personality traits com
  pared to adherent respondents. Pearson’s correlation analysis showed a weak negative relationship between neuroticism personality trait and adherence behaviour (
  P
   &lt; 0.05). There was also a statistically significant weak correlation (r = 0.1) between specific concern medication belief and adherence to medication among respondents in the study (
  P
   &lt; 0.05). Conclusion: Personality traits of diabetic patients can influence their adherence to treatment. Patients with neuroticism person
  ality trait and 
  specific concern medication belief tend to be non-adherent to medication. 
  Healthcare
   providers should therefore
   
  pay more attention to the personality traits 
  and medication beliefs 
  of patients 
  in providing effective management for diabetic patients.
 
</p></abstract><kwd-group><kwd>Personality Traits</kwd><kwd> Medication Beliefs</kwd><kwd> Adherence to Medication</kwd><kwd> Diabetes</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Chronic diseases such as diabetes mellitus require lifelong drug treatments which affect patients in many ways bringing about various restraints. Diabetes is a complex disorder requiring the continuous attention of both healthcare providers and patients. Even though individuals with diabetes mellitus (DM) have been shown to have an impact on treatment outcome by participating in the disease management, adherence to these activities has been found to be poor, especially when looking at long-term changes [<xref ref-type="bibr" rid="scirp.61391-ref1">1</xref>] . In particular, non-adherence to drug therapy is an important cause of treatment failure and a consequence of many chronic diseases, with a reported 30% - 80% of non-compliance among patients with Acquired Immune Deficiency Syndrome (AIDS), tuberculosis, hypertension and dyslipidaemia [<xref ref-type="bibr" rid="scirp.61391-ref2">2</xref>] .</p><p>The current prevalence of DM in Nigeria is in the region of 8% - 10% [<xref ref-type="bibr" rid="scirp.61391-ref3">3</xref>] . Three types are frequently recognised, namely, Type 1 DM (T1DM), Type 2 DM (T2DM) and gestational diabetes. T2DM is the most commonly documented form, accounting for about 90% - 95% of all cases of DM in most endocrine clinics [<xref ref-type="bibr" rid="scirp.61391-ref4">4</xref>] . Adherence can be defined as the extent to which the patient’s behaviour matches the agreed recommendations from the prescriber and the prescription. Factors associated with non-adherent behaviour include socioeconomic factors, therapy-related factors, condition-related factors, health care system factors and patient-related factors such as personality traits and patients’ beliefs about medicines [<xref ref-type="bibr" rid="scirp.61391-ref5">5</xref>] . Generally, only about half of all patients on medication are actually adherent [<xref ref-type="bibr" rid="scirp.61391-ref4">4</xref>] .</p><p>Among 150 diabetic patients sampled in New York City, 28% did not adhere to medications. Their beliefs about DM and the medications were significantly associated with the non-adherent behavior [<xref ref-type="bibr" rid="scirp.61391-ref6">6</xref>] . In Malaysia, a study conducted in a Primary Health Clinic (PHC) among 557 diabetic patients reported over half (53%) of the participants as being non-adherent to medication, with age, medication knowledge and co-morbidities being predictors of non-adherence [<xref ref-type="bibr" rid="scirp.61391-ref7">7</xref>] . In Nigeria, a study on the adherence to anti-diabetic drug therapy and self- management practices among type-2 diabetics conducted in the South west revealed that 59% of patients were not adherent due to various reasons including finance, side effects and perceived inefficacy of the anti-diabetic drugs [<xref ref-type="bibr" rid="scirp.61391-ref8">8</xref>] .</p><p>Adherence rates to both insulin and oral hypoglycaemic medications as low as 26.4% were reported among 220 DM patients in a study conducted in Ilorin, Nigeria [<xref ref-type="bibr" rid="scirp.61391-ref9">9</xref>] . An adherence rate of 72.5% to oral hypoglycaemic medications was however reported among 120 patients attending the family medicine clinic of a Federal Medical Centre in Eastern Nigeria [<xref ref-type="bibr" rid="scirp.61391-ref10">10</xref>] .</p><p>Although there is a paucity of local data about personality trait, patient medication beliefs and adherence, it has been documented that associations among patients’ personality trait, personal beliefs about medicines and self-reported adherence to medications exist [<xref ref-type="bibr" rid="scirp.61391-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.61391-ref11">11</xref>] - [<xref ref-type="bibr" rid="scirp.61391-ref14">14</xref>] . However, data from older studies revealed that medication beliefs and personality trait appeared to be more powerful predictors of reported adherence than the clinical and socio-demographic factors [<xref ref-type="bibr" rid="scirp.61391-ref12">12</xref>] - [<xref ref-type="bibr" rid="scirp.61391-ref14">14</xref>] .</p><p>Adherent behaviour is said to be associated with personal beliefs about the specific prescribed medication and its necessity for controlling illness balanced against concerns about the possible negative effects of medications [<xref ref-type="bibr" rid="scirp.61391-ref15">15</xref>] .</p><p>Measuring adherence to medications among DM patients would provide information about adherence rates in this environment. In addition, assessing associations among adherence, patients’ personality traits and medication beliefs can provide essential details about how these factors predict adherence serving as an essential tool for physicians, other health care providers, and public health practitioners. This can aid the counselling and effective communication with patients for improved medication and therapy adherence, better treatment outcomes and prevention of complications.</p><p>The general objective of this study was to assess adherence to medications among diabetic patients attending the diabetes clinic of a Tertiary Health Institution. The specific objectives were to assess the personality traits and personal beliefs of patients on medication for DM, to determine adherence to medication for DM among the patients, and to identify any association among personality traits, personal beliefs about medication and adherence to therapy among the patients.</p></sec><sec id="s2"><title>2. Materials and Methods</title><p>Lagos State is located in South-Western Nigeria and lies on longitude 3˚24'E and latitude 6˚27'N.<sup> </sup>Lagos State has an estimated population of 15 million people, is made up of 20 Local Government Areas, and 37 Local Council Development Areas. Ikeja, the capital of Lagos State is urban, with an area of about 46.2 sq∙Km and a population of about 313,196 inhabitants [<xref ref-type="bibr" rid="scirp.61391-ref16">16</xref>] .</p><p>Lagos State University Teaching Hospital, Ikeja (LASUTH) was commissioned as a General Hospital in 1955, as it was originally a Cottage Hospital and was subsequently upgraded to a Teaching Hospital in 2001 [<xref ref-type="bibr" rid="scirp.61391-ref17">17</xref>] . It is a multi-specialist hospital with a total bed complement of 484 and a staff complement of 1686 including 93 honorary consultants [<xref ref-type="bibr" rid="scirp.61391-ref18">18</xref>] . The premise also houses the Lagos State University College of Medicine (LASUCOM). The hospital runs several clinics such as the Chest clinic, Immunization clinic, Pediatrics clinic, Surgical clinics, Obstetrics and Gynecology clinics, General out-patient clinics, and the Medical clinics, including the Diabetes clinic where patients who are being managed for DM are attended to.</p><sec id="s2_1"><title>2.1. Measurement of Adherence</title><p>Measurement of adherence can only be an estimate of a patient’s actual behavior. Methods used include subjective ones such as provider and patient reports of adherence, use of standardized patient-administered questionnaires (General and Specific), while objective methods include counting of remaining dosage units, electronic monitoring device (Medication Event Monitoring System, MEMS) and the use of pharmacy prescription records [<xref ref-type="bibr" rid="scirp.61391-ref4">4</xref>] . No single method is considered optimal and feasible combinations are expected to provide more accurate information about adherence [<xref ref-type="bibr" rid="scirp.61391-ref4">4</xref>] . In Nigeria, pharmacy records may be inaccurate and misleading as patients patronize several pharmacies, MEMS would be financially unfeasible and so standardized patient-administered questionnaires are considered the most appropriate in these circumstances.</p></sec><sec id="s2_2"><title>2.2. Assessment of Personality Traits</title><p>In Psychology, the taxonomy of personality traits are collectively called the Big Five [<xref ref-type="bibr" rid="scirp.61391-ref19">19</xref>] . The Big Five Factors or personality traits are five broad domains or dimensions of personality that are used to describe human personality which are able to account for different traits in personality without overlapping. It has been shown that the Big Five personality traits show consistency in interviews, self-descriptions and observations and appear to be found across a wide range of participants of varying ages and cultures [<xref ref-type="bibr" rid="scirp.61391-ref20">20</xref>] . The five factors are openness, conscientiousness, extraversion, agreeableness, and neuroticism. These traits may be measured in a variety of ways including the use of Big Five Inventory (BFI), the International Personality Item Pool (IPIP), the Big Five aspect scales (BFAS), the Big Five mini markers, Ten Item Personality Inventory (TIPI), the NEO Personality Inventory-Revised (NEO PI-R) and the NEO Five Factor Inventory (NEO FFI), the last 2 being commercial [<xref ref-type="bibr" rid="scirp.61391-ref19">19</xref>] . However, many of these methods have too many items to be practicable in a clinical setting, and the very short TIPI would result in some measurement tradeoffs [<xref ref-type="bibr" rid="scirp.61391-ref20">20</xref>] . The BFI which is a 44-item inventory that measures an individual on the Big Five Factors (dimensions) of personality and further sub divides each factor into personality facets was therefore adopted as most appropriate for this study [<xref ref-type="bibr" rid="scirp.61391-ref21">21</xref>] .</p></sec><sec id="s2_3"><title>2.3. Study Population</title><p>The study population was selected from the diabetic patients receiving medications at the Diabetes Clinic of LASUTH.</p></sec><sec id="s2_4"><title>2.4. Study Design</title><p>The study is cross sectional and descriptive with the use of structured interviewer-administered questionnaires.</p></sec><sec id="s2_5"><title>2.5. Sample Size</title><p>Using an appropriate formula, the required sample size for the study was determined at 218.</p></sec><sec id="s2_6"><title>2.6. Sampling Method</title><p>Patients were selected using systematic random sampling method. A sampling interval of 3 was derived from 810 (average population of patients in 3 months)/242 (calculated sample size). Therefore, every 3<sup>rd</sup> patient who met the inclusion criteria was selected until the sample size had been attained.</p></sec><sec id="s2_7"><title>2.7. Inclusion Criteria</title><p>1) Patients must have been on anti-diabetic medications for at least 6 months.</p><p>2) Patients must be aged 15 or above.</p></sec><sec id="s2_8"><title>2.8. Exclusion Criteria</title><p>Patients who are critically ill were excluded from the study.</p></sec><sec id="s2_9"><title>2.9. Survey Instruments</title><p>An interviewer-administered structured questionnaire adapted from the General Beliefs about Medicines Questionnaire (BMQ) and the Medical Adherence Report Scale (MARS) used in studies conducted in Sweden was modified and used for the study [<xref ref-type="bibr" rid="scirp.61391-ref22">22</xref>] . The first section (section A) of the questionnaire elicited socio demographic information, section B dealt with medical and drug history, section C was about personality traits, section D elicited beliefs about medicines, while section E measured adherence to medications. All the statements in sections C to E were answered on a five-point Likert scale: 1 = strongly disagree, 2 = disagree, 3 = uncertain, 4 = agree and 5 = strongly agree.</p></sec><sec id="s2_10"><title>2.10. Data Collection</title><p>The questionnaires were administered by 3 research assistants who were trained for 2 days prior to data collection.</p></sec><sec id="s2_11"><title>2.11. Data Analysis</title><p>Mean scores were calculated for each participant and for all BMQ sub-parts from one to five. A higher mean indicated a stronger belief in the concept described.</p><p>The BFI scale scoring for Personality Trait was used. (“R” denotes reverse-scored items):</p><p>Extraversion: 1, 6R, 11, 16, 21R, 26, 31R (Range of Score = 7 - 35);</p><p>Agreeableness: 2R, 7, 12R, 17, 22, 27R, 32, 37R, 42 (Range of Score = 9 - 45);</p><p>Conscientiousness: 3, 8R, 13, 18R, 23R, 28, 33, 43R (Range of Score = 8 - 40);</p><p>Neuroticism: 4, 9R, 14, 19, 24R, 29, 34R, 36, 38, 39 (Range of Score = 10 - 50);</p><p>Openness: 5, 10, 15, 20, 25, 30, 35R, 40, 41R, 44 (Range of Score = 10 - 50).</p><p>The Beliefs About Medication Questionnaire (BMQ) had two sections; BMQ Specific which had Necessity Belief with three items and Concern Belief with five items; BMQ General had Harm Belief with two items, overuse belief with two items and Benefit Belief with one item. Each item is scored 1 for a positive response and 0 for a negative response.</p><p>The Medication Adherence Report Scale that was adapted had 6 items with Yes/No responses. Each positive response attracted one point while negative responses attracted zero. A total score less than 75% (4.5/6) was regarded as being non-adherent [<xref ref-type="bibr" rid="scirp.61391-ref23">23</xref>] .</p><p>Statistical analysis was conducted using Epi Info Software Version 3.5.1 (August 2008). Associations between proportions were determined using the chi square test, while differences in means were assessed using the Student’s test statistic. Relationships between Personality trait score, Medication Belief Score and Adherence scores were determined using Pearson’s correlation coefficient statistic. Tests of significance were performed using a 95% confidence interval with the level of significance set at P &lt; 0.05.</p><p>Data were summarized and key variables described. Outcome measures included personality traits, patients’ medication beliefs, medication adherence rates, and associations between the traits, beliefs and adherence rates.</p></sec><sec id="s2_12"><title>2.12. Ethical Considerations</title><p>Ethical clearance was obtained from the Health Research and Ethics Committee (HREC) of the Lagos State University Teaching Hospital, permission was obtained from the Chief Medical Director of LASUTH and the Consultants in charge of the clinic. In addition, respondents were also assured of the confidentiality of data collected and were provided the option of withdrawal at any point during the survey without any consequence on their management.</p></sec><sec id="s2_13"><title>2.13. Consent Procedure</title><p>Informed written consent was obtained from each respondent prior to data collection with the aid of a consent form.</p></sec><sec id="s2_14"><title>2.14. Study Limitations</title><p>Information obtained may be subject to courtesy and recall biases.</p></sec></sec><sec id="s3"><title>3. Results</title><p>A total number of 223 respondents were recruited into the study having met the inclusion criteria. The mean age of respondents in this study was 61.4 years. The Majority of the respondents 139 (62.3%) were females, male: female ratio was 1:1.7. Most of the respondents (70.4%) were married and about 21% were widowed. All the respondents had at least primary education. Thirty five percent had tertiary and postgraduate education. About 85% of respondents earned at least N 20,000 per month and the Median income of respondents was N 40,000 (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Most of the respondents (87.4%). had been diabetic for more than 2 years (48 months) with an average disease period of 10.3 years (123.0 months). Also, the average period of treatment for diabetes was 9.2 years (111.0 months). More than 58% of the participants had a co morbidity; mostly hypertension in about 91% of cases. More than two thirds (63.7%) of respondents were on more than three drugs at a time (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>The mean score for agreeable, conscientious, extraversion, neuroticism and openness personality traits among the respondents were 34.2, 31.1, 23.4, 26.7 and 34.3 respectively; While the mean score for necessity, concern, harm, overuse &amp; benefit beliefs among respondents were 9.0, 11.3, 4.2, 6.2 and 4.2 respectively (<xref ref-type="table" rid="table5">Table 5</xref>). The description and range of scores in the scales are outlined in the methodology.</p><p>On adherence, 37.2% of respondents reported they sometimes forget to take their drugs, while 28.7% sometimes decide to miss out a dose. About 72% of the participants reported they did not take their drugs a day before. Overall, 59.2% of respondents were adherent to their treatment while 40.8% were not. The mean total adherence score was 4.6 (<xref ref-type="table" rid="table3">Table 3</xref> and <xref ref-type="table" rid="table4">Table 4</xref>).</p><p>There was no statistically significant association between the age, marital status, level of education &amp; adherence to medication in this study. However, there was a statistically significant association between the gender of respondents and adherence to medication. A higher proportion of males (70.2%) were more likely to adhere to their medication compared to females (52.5%), and this was statistically significant (P &lt; 0.05) (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>There was no statistically significant association between the duration of being diabetic, duration of treatment, presence of a co morbidity and adherence to medication (P &gt; 0.05). Although, a higher proportion (62.7%) of respondents who were on more than three medications were adherent compared to those on three or less number of medications (51.9), this was not statistically significant (P &gt; 0.05) (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>There was a statistically significant difference in the mean neuroticism personality trait score of adherent compared to non-adherent respondents. The non-adherent respondents had a higher mean score of neuroticism personality (27.6) compared to adherent respondents (25.8) and this was statistically significant (P &lt; 0.05). There was no statistically significant difference in the mean extraversion, openness, agreeable and conscientious personality traits scores of adherent and non-adherent respondents (P &gt; 0.05). There was no statistically significant difference in the mean score of adherent and non-adherent respondents with necessity, harm, overuse and benefit medication beliefs (P &gt; 0.05). Although the mean concern medication belief of non-adherent respondents was higher (11.8) than the adherent group (11.0), this was however not statistically significant (P &gt; 0.05) (<xref ref-type="table" rid="table5">Table 5</xref>).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Association between socio-demographic &amp; adherence</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Variable</th><th align="center" valign="middle"  rowspan="2"  >Freq (%)</th><th align="center" valign="middle"  colspan="3"  >Adherence (N = 223)</th><th align="center" valign="middle"  rowspan="2"  >Statistics</th><th align="center" valign="middle"  rowspan="2"  >P value</th></tr></thead><tr><td align="center" valign="middle" >Non-adherence</td><td align="center" valign="middle"  colspan="2"  >Adherence</td></tr><tr><td align="center" valign="middle" >Age (years)</td><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;30</td><td align="center" valign="middle" >7 (3.1)</td><td align="center" valign="middle"  colspan="2"  >2 (28.6)</td><td align="center" valign="middle" >5 (71.4)</td><td align="center" valign="middle" >χ<sup>2</sup> = 7.7</td><td align="center" valign="middle" >0.054</td></tr><tr><td align="center" valign="middle" >30 - 40</td><td align="center" valign="middle" >7 (3.1)</td><td align="center" valign="middle"  colspan="2"  >5 (71.4)</td><td align="center" valign="middle" >2 (28.6)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >40 - 50</td><td align="center" valign="middle" >23 (10.3)</td><td align="center" valign="middle"  colspan="2"  >14 (60.9)</td><td align="center" valign="middle" >9 (39.1)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&gt;50</td><td align="center" valign="middle" >185 (83.1)</td><td align="center" valign="middle"  colspan="2"  >70 (37.8)</td><td align="center" valign="middle" >115 (62.2)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >NR</td><td align="center" valign="middle" >1 (0.4)</td><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >223 (100.0)</td><td align="center" valign="middle"  colspan="2"  >91 (41.0)</td><td align="center" valign="middle" >131 (59.0)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Mean &#177; SD</td><td align="center" valign="middle" >61.4&#177;13.1</td><td align="center" valign="middle"  colspan="2"  >59.7 &#177; 13.2</td><td align="center" valign="middle" >62.6 &#177; 13.0</td><td align="center" valign="middle" >t = 1.6</td><td align="center" valign="middle" >0.113</td></tr><tr><td align="center" valign="middle" >Median (range)</td><td align="center" valign="middle" >63.5 (15-93)</td><td align="center" valign="middle"  colspan="2"  >60.0 (13-85)</td><td align="center" valign="middle" >65.0 (12-93)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Gender</td><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >84 (37.7)</td><td align="center" valign="middle"  colspan="2"  >25 (29.8)</td><td align="center" valign="middle" >59 (70.2)</td><td align="center" valign="middle" >χ<sup>2</sup> = 6.8</td><td align="center" valign="middle" >0.007</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >139 (62.3)</td><td align="center" valign="middle"  colspan="2"  >66 (47.5)</td><td align="center" valign="middle" >73 (52.5)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >223 (100.0)</td><td align="center" valign="middle"  colspan="2"  >91 (40.8)</td><td align="center" valign="middle" >132 (59.2)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Marital status</td><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Single</td><td align="center" valign="middle" >9 (4.0)</td><td align="center" valign="middle"  colspan="2"  >4 (44.4)</td><td align="center" valign="middle" >5 (55.6)</td><td align="center" valign="middle" >χ<sup>2</sup> = 4.2</td><td align="center" valign="middle" >0.375</td></tr><tr><td align="center" valign="middle" >Married</td><td align="center" valign="middle" >157 (70.4)</td><td align="center" valign="middle"  colspan="2"  >66 (42.0)</td><td align="center" valign="middle" >91 (58.0)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Widowed</td><td align="center" valign="middle" >47 (21.1)</td><td align="center" valign="middle"  colspan="2"  >20 (42.6)</td><td align="center" valign="middle" >27 (57.4)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Separated</td><td align="center" valign="middle" >8 (3.6)</td><td align="center" valign="middle"  colspan="2"  >1 (12.5)</td><td align="center" valign="middle" >7 (87.5)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Divorced</td><td align="center" valign="middle" >2 (0.9)</td><td align="center" valign="middle"  colspan="2"  >0 (0.0)</td><td align="center" valign="middle" >2 (100)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >223 (100.0)</td><td align="center" valign="middle"  colspan="2"  >91 (40.8)</td><td align="center" valign="middle" >132 (59.2)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Educational level</td><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Primary</td><td align="center" valign="middle" >58 (26.0)</td><td align="center" valign="middle"  colspan="2"  >21 (36.2)</td><td align="center" valign="middle" >37 (63.8)</td><td align="center" valign="middle" >χ<sup>2</sup> = 1.5</td><td align="center" valign="middle" >0.675</td></tr><tr><td align="center" valign="middle" >Secondary</td><td align="center" valign="middle" >63 (28.3)</td><td align="center" valign="middle"  colspan="2"  >29 (46.0)</td><td align="center" valign="middle" >34 (54.0)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Tertiary</td><td align="center" valign="middle" >53 (23.8)</td><td align="center" valign="middle"  colspan="2"  >20 (37.8)</td><td align="center" valign="middle" >33 (62.2)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Postgraduate</td><td align="center" valign="middle" >25 (11.2)</td><td align="center" valign="middle"  colspan="2"  >11 (44.0)</td><td align="center" valign="middle" >14 (56.0)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >NR</td><td align="center" valign="middle" >24 (10.8)</td><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >223 (100.0)</td><td align="center" valign="middle"  colspan="2"  >81 (40.7)</td><td align="center" valign="middle" >118 (59.3)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Household income</td><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;20,000</td><td align="center" valign="middle" >33 (14.8)</td><td align="center" valign="middle"  colspan="2"  >12 (36.4)</td><td align="center" valign="middle" >21 (63.6)</td><td align="center" valign="middle" >χ<sup>2</sup> = 1.5</td><td align="center" valign="middle" >0.689</td></tr><tr><td align="center" valign="middle" >20,000 - 50,000</td><td align="center" valign="middle" >102 (45.7)</td><td align="center" valign="middle"  colspan="2"  >44 (43.1)</td><td align="center" valign="middle" >58 (56.9)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >51,000 - 100,000</td><td align="center" valign="middle" >34 (15.2)</td><td align="center" valign="middle"  colspan="2"  >17 (50.0)</td><td align="center" valign="middle" >17 (50.0)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&gt;100,000</td><td align="center" valign="middle" >11 (4.9)</td><td align="center" valign="middle"  colspan="2"  >4 (36.4)</td><td align="center" valign="middle" >7 (63.6)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >NR</td><td align="center" valign="middle" >43 (19.3)</td><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >223 (100.0)</td><td align="center" valign="middle"  colspan="2"  >77 (42.8)</td><td align="center" valign="middle" >103 (57.2)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Mean &#177; SD</td><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  >51,402.6 &#177; 54,041.7</td><td align="center" valign="middle" >49,789.3 &#177; 44,040.9</td><td align="center" valign="middle" >t = 0.2</td><td align="center" valign="middle" >0.826</td></tr><tr><td align="center" valign="middle" >Median</td><td align="center" valign="middle" >40,000</td><td align="center" valign="middle"  colspan="2"  >30,000</td><td align="center" valign="middle" >40,000</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>NR: Non Response.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Association between drug history &amp; adherence</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Variable</th><th align="center" valign="middle"  rowspan="2"  >Freq (%)</th><th align="center" valign="middle"  colspan="2"  >Adherence</th><th align="center" valign="middle"  rowspan="2"  >Statistics</th><th align="center" valign="middle"  rowspan="2"  >P value</th></tr></thead><tr><td align="center" valign="middle" >Non-adherence</td><td align="center" valign="middle" >Adherence</td></tr><tr><td align="center" valign="middle" >Duration of being diabetic (months)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >6 - 12</td><td align="center" valign="middle" >10 (4.5)</td><td align="center" valign="middle" >5 (50.0)</td><td align="center" valign="middle" >5 (50.0)</td><td align="center" valign="middle" >χ<sup>2</sup> = 3.1</td><td align="center" valign="middle" >0.371</td></tr><tr><td align="center" valign="middle" >13 - 24</td><td align="center" valign="middle" >18 (8.1)</td><td align="center" valign="middle" >7 (38.9)</td><td align="center" valign="middle" >11 (61.1)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >25 - 48</td><td align="center" valign="middle" >36 (16.1)</td><td align="center" valign="middle" >19 (52.8)</td><td align="center" valign="middle" >17 (47.2)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&gt;48</td><td align="center" valign="middle" >159 (71.3)</td><td align="center" valign="middle" >60 (37.8)</td><td align="center" valign="middle" >99 (62.2)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >223 (100.0)</td><td align="center" valign="middle" >91 (40.8)</td><td align="center" valign="middle" >132 (59.2)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Mean &#177; SD</td><td align="center" valign="middle" >123.0 &#177; 98.5</td><td align="center" valign="middle" >121.5 &#177; 101.9</td><td align="center" valign="middle" >124.3 &#177; 96.6</td><td align="center" valign="middle" >t = 0.2</td><td align="center" valign="middle" >0.834</td></tr><tr><td align="center" valign="middle" >Median</td><td align="center" valign="middle" >96.0</td><td align="center" valign="middle" >84.0</td><td align="center" valign="middle" >96.0</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Duration on treatment (month)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >6 - 12</td><td align="center" valign="middle" >13 (5.8)</td><td align="center" valign="middle" >7 (53.8)</td><td align="center" valign="middle" >6 (46.2)</td><td align="center" valign="middle" >χ<sup>2</sup> = 3.9</td><td align="center" valign="middle" >0.270</td></tr><tr><td align="center" valign="middle" >13 - 24</td><td align="center" valign="middle" >23 (10.3)</td><td align="center" valign="middle" >7 (30.4)</td><td align="center" valign="middle" >16 (69.6)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >25 - 48</td><td align="center" valign="middle" >37 (16.6)</td><td align="center" valign="middle" >19 (51.4)</td><td align="center" valign="middle" >18 (48.6)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&gt;48</td><td align="center" valign="middle" >150 (67.3)</td><td align="center" valign="middle" >58 (38.7)</td><td align="center" valign="middle" >92 (61.3)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >223 (100.0)</td><td align="center" valign="middle" >91 (40.8)</td><td align="center" valign="middle" >132 (59.2)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Mean &#177; SD</td><td align="center" valign="middle" >111.0 &#177; 92.0</td><td align="center" valign="middle" >106.6 &#177; 91.1</td><td align="center" valign="middle" >114.1 &#177; 93.1</td><td align="center" valign="middle" >t = 0.6</td><td align="center" valign="middle" >0.352</td></tr><tr><td align="center" valign="middle" >Median</td><td align="center" valign="middle" >84.0</td><td align="center" valign="middle" >72.0</td><td align="center" valign="middle" >84.0</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Co-morbidity</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >131 (58.7)</td><td align="center" valign="middle" >54 (41.2)</td><td align="center" valign="middle" >77 (58.8)</td><td align="center" valign="middle" >χ<sup>2</sup> = 0.1</td><td align="center" valign="middle" >0.454</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >79 (35.4)</td><td align="center" valign="middle" >34 (43.0)</td><td align="center" valign="middle" >45 (57.0)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >NR</td><td align="center" valign="middle" >13 (5.8)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >223 (100.0)</td><td align="center" valign="middle" >88 (41.9)</td><td align="center" valign="middle" >122 (58.1)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >No. of medications on</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >12 (5.4)</td><td align="center" valign="middle" >6 (50.0)</td><td align="center" valign="middle" >6 (50.0)</td><td align="center" valign="middle" >χ<sup>2</sup> = 2.3</td><td align="center" valign="middle" >0.302</td></tr><tr><td align="center" valign="middle" >2 - 3</td><td align="center" valign="middle" >65 (29.1)</td><td align="center" valign="middle" >31 (47.7)</td><td align="center" valign="middle" >34 (52.3)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&gt;3</td><td align="center" valign="middle" >142 (63.7)</td><td align="center" valign="middle" >53 (37.3)</td><td align="center" valign="middle" >89 (62.7)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >NR</td><td align="center" valign="middle" >4 (1.8)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >223 (100.0)</td><td align="center" valign="middle" >89 (40.8)</td><td align="center" valign="middle" >129 (59.2)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Mean No. of medications &#177; SD</td><td align="center" valign="middle" >4.5 &#177;4.3</td><td align="center" valign="middle" >4.7 &#177; 6.4</td><td align="center" valign="middle" >4.4 &#177; 1.8</td><td align="center" valign="middle" >t = 0.6</td><td align="center" valign="middle" >0.581</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Adherence to medication among respondents</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Adherence to medication (N = 223)</th><th align="center" valign="middle" >Yes</th><th align="center" valign="middle" >No</th><th align="center" valign="middle" >NR</th></tr></thead><tr><td align="center" valign="middle" >Sometimes, I forget to take my medicine</td><td align="center" valign="middle" >83 (37.2)</td><td align="center" valign="middle" >136 (61.0)</td><td align="center" valign="middle" >4 (1.8)</td></tr><tr><td align="center" valign="middle" >Sometimes, I alter the dose of my medicine</td><td align="center" valign="middle" >53 (23.8)</td><td align="center" valign="middle" >166 (74.4)</td><td align="center" valign="middle" >4 (1.8)</td></tr><tr><td align="center" valign="middle" >I stopped taking my medicines for a while</td><td align="center" valign="middle" >53 (23.8)</td><td align="center" valign="middle" >166 (74.4)</td><td align="center" valign="middle" >4 (1.8)</td></tr><tr><td align="center" valign="middle" >Sometimes, I decide to miss out a dose</td><td align="center" valign="middle" >64 (28.7)</td><td align="center" valign="middle" >155 (69.5)</td><td align="center" valign="middle" >4 (1.8)</td></tr><tr><td align="center" valign="middle" >Sometimes, I take less than instructed</td><td align="center" valign="middle" >29 (13.0)</td><td align="center" valign="middle" >190 (85.2)</td><td align="center" valign="middle" >4 (1.8)</td></tr><tr><td align="center" valign="middle" >Did you take your drug yesterday</td><td align="center" valign="middle" >160 (71.7)</td><td align="center" valign="middle" >59 (26.5)</td><td align="center" valign="middle" >4 (1.8)</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Medication adherence scores</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Frequency (N = 223) (percent)</th></tr></thead><tr><td align="center" valign="middle" >Adherence</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Non-adherence</td><td align="center" valign="middle" >91 (40.8)</td></tr><tr><td align="center" valign="middle" >Adherence</td><td align="center" valign="middle" >132 (59.2)</td></tr><tr><td align="center" valign="middle" >Adherence score</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Mean &#177; SD</td><td align="center" valign="middle" >4.6 &#177; 1.5</td></tr><tr><td align="center" valign="middle" >Median (range)</td><td align="center" valign="middle" >5.0 (0 - 6)</td></tr></tbody></table></table-wrap><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Means Score of patients’ personality traits, beliefs about medicines (BMQ), comparing non-adherent with adherent patients</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Variables</th><th align="center" valign="middle"  rowspan="2"  >Total mean score &#177; SD</th><th align="center" valign="middle"  colspan="2"  >Scale score means (SD) (n = 223)</th><th align="center" valign="middle"  rowspan="2"  >t test</th><th align="center" valign="middle"  rowspan="2"  >P value</th></tr></thead><tr><td align="center" valign="middle" >Non-adherence</td><td align="center" valign="middle" >Adherence</td></tr><tr><td align="center" valign="middle" >Personality trait</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Neuroticism</td><td align="center" valign="middle" >26.7 &#177; 4.7</td><td align="center" valign="middle" >27.6 &#177; 5.0</td><td align="center" valign="middle" >25.8 &#177; 4.4</td><td align="center" valign="middle" >2.6</td><td align="center" valign="middle" >0.011</td></tr><tr><td align="center" valign="middle" >Extraversion</td><td align="center" valign="middle" >23.4 &#177; 3.8</td><td align="center" valign="middle" >23.1 &#177; 3.5</td><td align="center" valign="middle" >23.6 &#177; 3.9</td><td align="center" valign="middle" >0.9</td><td align="center" valign="middle" >0.375</td></tr><tr><td align="center" valign="middle" >Conscientiousness</td><td align="center" valign="middle" >31.1 &#177; 3.7</td><td align="center" valign="middle" >31.0 &#177; 3.8</td><td align="center" valign="middle" >31.1 &#177; 3.7</td><td align="center" valign="middle" >0.2</td><td align="center" valign="middle" >0.814</td></tr><tr><td align="center" valign="middle" >Openness</td><td align="center" valign="middle" >34.3 &#177; 5.0</td><td align="center" valign="middle" >34.3 &#177; 5.2</td><td align="center" valign="middle" >34.3 &#177; 4.9</td><td align="center" valign="middle" >0.0</td><td align="center" valign="middle" >0.980</td></tr><tr><td align="center" valign="middle" >Agreeableness</td><td align="center" valign="middle" >34.2 &#177; 4.3</td><td align="center" valign="middle" >34.3 &#177; 4.7</td><td align="center" valign="middle" >34.2 &#177; 4.1</td><td align="center" valign="middle" >0.1</td><td align="center" valign="middle" >0.891</td></tr><tr><td align="center" valign="middle" >Medication belief</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >BMQ specific</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Necessity</td><td align="center" valign="middle" >9.0 &#177; 2.2</td><td align="center" valign="middle" >8.8 &#177; 2.3</td><td align="center" valign="middle" >9.1 &#177; 2.2</td><td align="center" valign="middle" >0.9</td><td align="center" valign="middle" >0.347</td></tr><tr><td align="center" valign="middle" >Concern</td><td align="center" valign="middle" >11.3 &#177; 3.2</td><td align="center" valign="middle" >11.8 &#177; 3.1</td><td align="center" valign="middle" >11.0 &#177; 3.2</td><td align="center" valign="middle" >1.8</td><td align="center" valign="middle" >0.078</td></tr><tr><td align="center" valign="middle" >BMQ general</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Harm</td><td align="center" valign="middle" >4.2 &#177; 1.9</td><td align="center" valign="middle" >4.4 &#177; 2.1</td><td align="center" valign="middle" >4.1 &#177; 1.8</td><td align="center" valign="middle" >1.0</td><td align="center" valign="middle" >0.331</td></tr><tr><td align="center" valign="middle" >Overuse</td><td align="center" valign="middle" >6.2 &#177; 2.2</td><td align="center" valign="middle" >6.5 &#177; 2.2</td><td align="center" valign="middle" >6.1 &#177; 2.2</td><td align="center" valign="middle" >1.2</td><td align="center" valign="middle" >0.233</td></tr><tr><td align="center" valign="middle" >Benefit</td><td align="center" valign="middle" >4.2 &#177; 0.9</td><td align="center" valign="middle" >4.2 &#177; 0.9</td><td align="center" valign="middle" >4.2 &#177; 0.9</td><td align="center" valign="middle" >0.5</td><td align="center" valign="middle" >0.610</td></tr></tbody></table></table-wrap><p>There was a statistically significant but weak negative correlation (r = −0.1) between neuroticism personality trait and adherence. The higher the neuroticism, the lower the adherence (P &lt; 0.05). There was also a statistically significant correlation (r = 0.2) between concern medication belief and adherence to medication. The higher the concern medication belief, the lower the adherence to medication and this was statistically significant (P &lt; 0.05) (<xref ref-type="table" rid="table6">Table 6</xref>).</p></sec><sec id="s4"><title>4. Discussion</title><p>We assessed the personality traits, medication beliefs and adherence to anti diabetic treatment among patients attending the Diabetic Clinic of Lagos State University Teaching Hospital Lagos. The mean age of respondents in this study was 61.4 which was similar to what was reported in other studies [<xref ref-type="bibr" rid="scirp.61391-ref6">6</xref>] . Most of the patients on treatment for chronic condition like diabetes are usually in their middle and old age [<xref ref-type="bibr" rid="scirp.61391-ref3">3</xref>] . In this study, the majority of the respondents 139 (62.3%) were females. As in most other studies, females tend to have better health seeking behaviours than men [<xref ref-type="bibr" rid="scirp.61391-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.61391-ref8">8</xref>] .</p><p>The average period respondents in this study had been diabetic was 10.3 years (123 months) and the average</p><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Correlation between respondents’ personality traits, medication beliefs and level of adherence</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  colspan="3"  >Adherence</th></tr></thead><tr><td align="center" valign="middle" >r</td><td align="center" valign="middle" >F test</td><td align="center" valign="middle" >P value</td></tr><tr><td align="center" valign="middle" >Personality</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Neuroticism</td><td align="center" valign="middle" >−0.1</td><td align="center" valign="middle" >4.8</td><td align="center" valign="middle" >0.049</td></tr><tr><td align="center" valign="middle" >Extraversion</td><td align="center" valign="middle" >0.1</td><td align="center" valign="middle" >2.8</td><td align="center" valign="middle" >0.094</td></tr><tr><td align="center" valign="middle" >Conscientiousness</td><td align="center" valign="middle" >0.0</td><td align="center" valign="middle" >0.5</td><td align="center" valign="middle" >0.471</td></tr><tr><td align="center" valign="middle" >Openness</td><td align="center" valign="middle" >0.0</td><td align="center" valign="middle" >0.5</td><td align="center" valign="middle" >0.492</td></tr><tr><td align="center" valign="middle" >Agreeableness</td><td align="center" valign="middle" >0.0</td><td align="center" valign="middle" >0.1</td><td align="center" valign="middle" >0.805</td></tr><tr><td align="center" valign="middle" >Medication belief</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >BMQ specific</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Necessity</td><td align="center" valign="middle" >0.1</td><td align="center" valign="middle" >2.3</td><td align="center" valign="middle" >0.136</td></tr><tr><td align="center" valign="middle" >Concern</td><td align="center" valign="middle" >-0.2</td><td align="center" valign="middle" >6.7</td><td align="center" valign="middle" >0.010</td></tr><tr><td align="center" valign="middle" >BMQ general</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Harm</td><td align="center" valign="middle" >0.0</td><td align="center" valign="middle" >0.9</td><td align="center" valign="middle" >0.346</td></tr><tr><td align="center" valign="middle" >Overuse</td><td align="center" valign="middle" >0.0</td><td align="center" valign="middle" >0.9</td><td align="center" valign="middle" >0.342</td></tr><tr><td align="center" valign="middle" >Benefit</td><td align="center" valign="middle" >0.0</td><td align="center" valign="middle" >0.1</td><td align="center" valign="middle" >0.769</td></tr></tbody></table></table-wrap><p>period they had been on treatment for diabetes was 9.2 years (111 months). As in most studies, the average period patients had been diabetic was 10 years and above [<xref ref-type="bibr" rid="scirp.61391-ref5">5</xref>] . More than 58% of respondents from this study had a co morbidity; mostly hypertension in about 91%. This is also comparable with findings from other studies. In an Ethiopian study on Diabetics, more than 61% of respondents had hypertension as a co-morbidity [<xref ref-type="bibr" rid="scirp.61391-ref24">24</xref>] .</p><p>The results from this study also showed that 59.2% of respondents were adherent to their treatment while 40.8% were not. Proportions of non-adherent patients vary from study to study. A US survey reported that 28% of patients were non adherent [<xref ref-type="bibr" rid="scirp.61391-ref5">5</xref>] , which is similar to findings from a study done in an eastern part of Nigeria which reported a non-adherence rate of 27.5% [<xref ref-type="bibr" rid="scirp.61391-ref9">9</xref>] . However higher figures of non-adherence (53.0%) were recorded in the Malaysian study [<xref ref-type="bibr" rid="scirp.61391-ref6">6</xref>] , and another study conducted in the Middle belt of Nigeria which reported that 73.6% of respondents were not adherent [<xref ref-type="bibr" rid="scirp.61391-ref8">8</xref>] .</p><p>In this study, there was a statistically significant association between the gender of respondents and adherence to medication. This is similar to the findings of the study done in central Nigeria [<xref ref-type="bibr" rid="scirp.61391-ref8">8</xref>] . However, unlike findings from some other studies, there was no statistically significant association between the respondents’ age, marital status, level of education, co morbidity, and duration of being diabetic and adherence to medication in this study [<xref ref-type="bibr" rid="scirp.61391-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.61391-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.61391-ref9">9</xref>] .</p><p>In this study, there is a relationship between higher score in neuroticism personality trait and non-adherence to medication. People with high scores on neuroticism have a higher propensity to display worry, anxiety and vulnerability to stress. In comparison, low scorers on this personality trait are more inclined to have an even-tempered disposition [<xref ref-type="bibr" rid="scirp.61391-ref25">25</xref>] . The behavioural tendencies associated with higher scores on neuroticism may explain the non-adherence behaviour among the respondents in this study. The findings are in line with previous research findings showing associations between higher scores neuroticism and non-adherence to long- term medication treatment [<xref ref-type="bibr" rid="scirp.61391-ref13">13</xref>] . And it is also similar to findings from a study on personality and adherence to antibiotic therapy among the Swedish population [<xref ref-type="bibr" rid="scirp.61391-ref14">14</xref>] . In this study, there was no statistically significant relationship between extraversion, openness, agreeable and conscientious personality traits and non-adherence behaviour of respondents. This finding was at variance with reports from a study on personality and adherence to antibiotic therapy among Swedish population which showed a relationship between agreeableness &amp; conscientiousness personality traits and adherence to medication [<xref ref-type="bibr" rid="scirp.61391-ref14">14</xref>] .</p><p>Furthermore, there was association between adherence and beliefs about specific concerns. This is similar to findings from a study from the UK on predictors of adherence to secondary preventive treatment after stroke, associations between BMQ-specific (Necessity and Concern) and adherence testing in which statistically significant associations were found with subscale Concern [<xref ref-type="bibr" rid="scirp.61391-ref26">26</xref>] . In another study among patients with rheumatoid arthritis, Concerns scores for non-adherent participants were higher than for the adherent group [<xref ref-type="bibr" rid="scirp.61391-ref27">27</xref>] . Findings from this study also showed that the adherent respondents have higher specific necessity belief and lower general harm &amp; overuse beliefs which was not statistically significant, but in keeping with findings from other studies [<xref ref-type="bibr" rid="scirp.61391-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.61391-ref28">28</xref>] . Most studies about medication adherence concluded that negative beliefs about medications could serve as powerful barriers to successful adherence [<xref ref-type="bibr" rid="scirp.61391-ref29">29</xref>] -[<xref ref-type="bibr" rid="scirp.61391-ref31">31</xref>] .</p></sec><sec id="s5"><title>5. Conclusions</title><p>Although methods involved in adherence studies differ, the level of adherence identified in this study is similar to findings from previous studies.</p><p>Personality traits of diabetic patients on anti-diabetics can influence their adherence to treatment and patients with neuroticism personality trait particularly tend to be non-adherent to medication. Specific concern medication belief tends to be related to non-adherence to medications and negative medication belief can impair adherence to long-term medications. Concerns about long-term effects of anti-diabetic medications should be addressed by healthcare workers to minimize concerns and consequently improve medication adherence. Also, healthcare providers should also pay more attention to the personality traits of patients, especially those with neuroticism personality during medication counseling.</p></sec><sec id="s6"><title>Acknowledgements</title><p>The authors thank Drs. Abdurraheem-Salami Ibipo and Andrew Airauhi for supervising the data collection process of this study.</p></sec><sec id="s7"><title>Cite this paper</title><p>AdeyinkaAdeniran,ModupeAkinyinka,Kikelomo O.Wright,Omowumi Q.Bakare,Olayinka O.Goodman,Yetunde A.Kuyinu,Olumuyiwa O.Odusanya,AkinOsibogun, (2015) Personality Traits, Medication Beliefs &amp; Adherence to Medication among Diabetic Patients Attending the Diabetic Clinic in a Teaching Hospital in Southwest Nigeria. Journal of Diabetes Mellitus,05,319-329. doi: 10.4236/jdm.2015.54039</p></sec><sec id="s8"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.61391-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Shriastava, S.R., Shrivastava, P.S. and Ramasamy, J. (2013) Role of Self-Care in Management of Diabetes Mellitus. Journal of Diabetes &amp; Metabolic Disorders, 12, 14. http://dx.doi.org/10.1186/2251-6581-12-14</mixed-citation></ref><ref id="scirp.61391-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Bezie, Y., Molina, M., Hernandez, N., Batista, R., Niang, S. and Huet, D. (2008) Therapeutic Compliance: A Prospective Analysis of Various Factors Involved in the Adherence Rate in Type 2 Diabetes.http://www.em-consulte.com/en/article/80533</mixed-citation></ref><ref id="scirp.61391-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Ogbera, A.O. and Ekpebegh, C. (2014) Diabetes Mellitus in Nigeria: The Past, Present and Future. World Journal of Diabetes, 5, 905-911. http://dx.doi.org/10.4239/wjd.v5.i6.905</mixed-citation></ref><ref id="scirp.61391-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">WHO (2015) Adherence to Long-Term Therapies: Evidence for Action [Internet].http://www.who.int/chp/knowledge/publications/adherence_report/en/</mixed-citation></ref><ref id="scirp.61391-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Mann, D.M., Ponieman, D., Leventhal, H. and Halm, E.A. (2009) Predictors of Adherence to Diabetic Medications: The Role of Disease and Medication Beliefs. Journal of Behavioral Medicine, 32, 278-284.http://dx.doi.org/10.1007/s10865-009-9202-y</mixed-citation></ref><ref id="scirp.61391-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Ahmad, N.S., Ramli, A., Islahudin, F. and Paraidathathu, T. (2013) Medication Adherence in Patients with Type 2 Diabetes Mellitus at Primary Health Clinics in Malaysia. Patient Preference and Adherence, 7, 525-530.</mixed-citation></ref><ref id="scirp.61391-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Yusuff, K.B., Obe, O. and Joseph, B.Y. (2008) Adherence to Anti-Diabetic Drug Therapy and Self Management Practices among Type-2 Diabetics in Nigeria. Pharmacy World &amp; Science, 30, 876-883.http://dx.doi.org/10.1007/s11096-008-9243-2</mixed-citation></ref><ref id="scirp.61391-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Abdulazeez, F.I., Omole, M. and Ojulari, S.L. (2014) Medication Adherence amongst Diabetic Patients in a Tertiary Healthcare Institution in Central Nigeria. Tropical Journal of Pharmaceutical Research, 13, 997-1001.http://dx.doi.org/10.4314/tjpr.v13i6.25</mixed-citation></ref><ref id="scirp.61391-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Pascal, I.G.U., Ofoedu, J.N., Uchenna, N.P., Nkwa, A.A. and Uchamma, G.E. (2012) Blood Glucose Control and Medication Adherence among Adult Type 2 Diabetic Nigerians Attending a Primary Care Clinic in Under-Resourced Environment of Eastern Nigeria. North American Journal of Medical Sciences, 4, 310-315.http://dx.doi.org/10.4103/1947-2714.98590</mixed-citation></ref><ref id="scirp.61391-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Sjolander, M., Eriksson, M. and Glader, E.-L. (2013) The Association between Patients’ Beliefs about Medicines and Adherence to Drug Treatment after Stroke: A Cross-Sectional Questionnaire Survey. BMJ, 3, e003551.http://dx.doi.org/10.1136/bmjopen-2013-003551</mixed-citation></ref><ref id="scirp.61391-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Menckeberg, T.T., Bouvy, M.L., Bracke, M., Kaptein, A.A., Leufkens, H.G., Raaijmakers, J., et al. (2008) Beliefs about Medicines Predict Refill Adherence to Inhaled Corticosteroids. Journal of Psychosomatic Research, 64, 47-54.http://dx.doi.org/10.1016/j.jpsychores.2007.07.016</mixed-citation></ref><ref id="scirp.61391-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Horne, R. and Weinman, J. (1999) Patients’ Beliefs about Prescribed Medicines and Their Role in Adherence to Treatment in Chronic Physical Illness. Journal of Psychosomatic Research, 47, 555-567.http://dx.doi.org/10.1016/S0022-3999(99)00057-4</mixed-citation></ref><ref id="scirp.61391-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Bruce, J.M., Hancock, L.M., Arnett, P. and Lynch, S. (2010) Treatment Adherence in Multiple Sclerosis: Association with Emotional Status, Personality, and Cognition. Journal of Behavioral Medicine, 33, 219-227.http://dx.doi.org/10.1007/s10865-010-9247-y</mixed-citation></ref><ref id="scirp.61391-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Axelsson, M. (2013) Report on Personality and Adherence to Antibiotic Therapy: A Population-Based Study. BMC Psychology, 1, 24. http://dx.doi.org/10.1186/2050-7283-1-24</mixed-citation></ref><ref id="scirp.61391-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Horne, R., Weinman, J. and Hankins, M. (1999) The Beliefs about Medicines Questionnaire: The Development and Evaluation of a New Method for Assessing the Cognitive Representation of Medication. Psychology &amp; Health, 14, 1-24. http://dx.doi.org/10.1080/08870449908407311</mixed-citation></ref><ref id="scirp.61391-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Legal Notice on Publication of the Details of the Breakdown of the National and State Provisional Totals 2006 Census. Federal Republic of Nigeria Official Gazette (2007) http://www.nigerianstat.gov.ng/Connections/Pop2006.pdf</mixed-citation></ref><ref id="scirp.61391-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">LASUTH: In Pursuit of Unparalleled Health Care Delivery (2008)</mixed-citation></ref><ref id="scirp.61391-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">About LASUTH. Lagos State University Teaching Hospital (2010) http://www.lasuth.org/</mixed-citation></ref><ref id="scirp.61391-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Srivastava, S. (2015) Measuring the Big Five Personality Domains. http://pages.uoregon.edu/sanjay/bigfive.html</mixed-citation></ref><ref id="scirp.61391-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Schacter, D.S., Gilbert, D.T. and Wegner, D.M. (2011) Psychology. 2nd Edition, Worth, New York, 474-475.</mixed-citation></ref><ref id="scirp.61391-ref21"><label>21</label><mixed-citation publication-type="book" xlink:type="simple">John, O.P. and Srivastava, S. (1999) The Big-Five Trait Taxonomy: History, Measurement, and Theoretical Perspectives. In: Pervin, L.A. and John, O.P., Eds., Handbook of Personality: Theory and Research, Guilford Press, New York, 102-138.</mixed-citation></ref><ref id="scirp.61391-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Mardby, A. (2008) General Beliefs about Medicines among Pharmacy Clients, Healthcare Students and Professionals-Group Differences and Association with Adherence. Intellecta DocuSys AB, Vastra Frolunda, Sweden, 13-21.</mixed-citation></ref><ref id="scirp.61391-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Alhewiti, A. (2014) Adherence to Long-Term Therapies and Beliefs about Medications. International Journal of Family Medicine, 2014, Article ID: 479596.http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3943193&amp;tool=pmcentrez&amp;rendertype=abstract</mixed-citation></ref><ref id="scirp.61391-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Nasir, T.W., Mulugeta, T.A. and Sadikalmahdi, H. (2011) Medication Adherence in Diabetes Mellitus and Self Management Practices among Type 2 Diabetics in Ethiopia. North American Journal of Medical Sciences, 3, 418-423.</mixed-citation></ref><ref id="scirp.61391-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Costa Jr., P.T. and McCrae, R.R. (1992) Revised NEO Personality Inventory (NEO-PI-R) and NEO Five-Factor Inventory (NEO-FFI) Professional Manual. Psychological Assessment Resources, Odessa.</mixed-citation></ref><ref id="scirp.61391-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">O’Carroll, R., Whittaker, J., Hamilton, B., et al. (2011) Predictors of Adherence to Secondary Preventive Medication in Stroke Patients. Annals of Behavioral Medicine, 41, 383-490. http://dx.doi.org/10.1007/s12160-010-9257-6</mixed-citation></ref><ref id="scirp.61391-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Neame, R. (2005) Beliefs about Medications: A Questionnaire Survey of People with Rheumatoid Arthritis. Rheumatology, 44, 762-767. http://www.rheumatology.oupjournals.org/cgi/doi/10.1093/rheumatology/keh587http://dx.doi.org/10.1093/rheumatology/keh587</mixed-citation></ref><ref id="scirp.61391-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Phatak, H.M. and Thomas III, J. (2006) Relationship between Beliefs about Medications and Nonadherence to Prescribed Chronic Medications. Annals of Pharmacotherapy, 40, 1737-1742. http://dx.doi.org/10.1345/aph.1H153</mixed-citation></ref><ref id="scirp.61391-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Gatti, M.E., Jacobson, K.L., Gazmararian, J.A., Schmotzer, B. and Kripalani, S. (2009) Relationships between Beliefs about Medications and Adherence. American Journal of Health-System Pharmacy, 66, 657-664.http://dx.doi.org/10.2146/ajhp080064</mixed-citation></ref><ref id="scirp.61391-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Iihara, N., Tsukamoto, T., Morita, S., Miyoshi, C., Takabatake, K. and Kurosaki, Y. (2004) Beliefs of Chronically Ill Japanese Patients That Lead to Intentional Non-Adherence to Medication. Journal of Clinical Pharmacy and Therapeutics, 29, 417-424. http://dx.doi.org/10.1111/j.1365-2710.2004.00580.x</mixed-citation></ref><ref id="scirp.61391-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Mardby, A.C., Akerlind, I. and Jorgensen, T. (2007) Beliefs about Medicines and Self-Reported Adherence among Pharmacy Clients. Patient Education and Counseling, 69, 158-164. http://dx.doi.org/10.1016/j.pec.2007.08.011</mixed-citation></ref></ref-list></back></article>